| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |